of the glutamatergic system plays an important role in the pathophysiology of
multiple sclerosis (MS). Apart from
Sufianov, A.,
Kostin, A.,
Begliarzade, S.,
Kudriashov, V.,
Ilyasova, T.,
Liang, Y.,
Mukhamedzyanov, A.,
Beylerli, O. (2023) , stroke, gangrene of the lower extremities, blindness and chronic renal
failure. As a result, the study